Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Prospective, non-randomized multicenter study on the safety and efficacy of combination
therapy with bendamustine and rituximab for chronic cold agglutinin disease.